| dbo:abstract |
Noxxon Pharma is a biotechnology company founded in 1997 in Berlin, Germany and is focused on improving cancer treatment by targeting the tumor microenvironment. Noxxon Pharma N.V. is listed on Euronext Growth, Paris (ALNOX). The company is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa). Noxxon Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to natural occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror." The L-RNA are resistant to the natural RNA nuclease enzymes. (en) |
| dbo:foundingYear |
1997-01-01 (xsd:gYear) |
| dbo:location |
dbr:Berlin dbr:Germany |
| dbo:numberOfEmployees |
10 (xsd:nonNegativeInteger) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/NOXXON_logo_HD2.png?width=300 |
| dbo:type |
dbr:Aktiengesellschaft |
| dbo:wikiPageExternalLink |
http://www.noxxon.com/ |
| dbo:wikiPageID |
39945332 (xsd:integer) |
| dbo:wikiPageLength |
5455 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1110582287 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Berlin dbr:Berlin,_Germany dbc:Biotechnology_companies_established_in_1997 dbr:L-Ribonucleic_acid_aptamer dbr:Nuclease dbr:Stromal_cell-derived_factor_1 dbr:Germany dbr:Anemia dbc:Pharmaceutical_companies_established_in_1997 dbc:German_brands dbr:Aktiengesellschaft dbr:Diabetic_nephropathy dbc:Biotechnology_companies_of_Germany dbc:Pharmaceutical_companies_of_Germany dbc:German_companies_established_in_1997 dbc:Medical_and_health_organisations_based_in_Berlin dbr:CCL2 dbr:Spiegel_(US_retailer) |
| dbp:foundation |
1997 (xsd:integer) |
| dbp:homepage |
http://www.noxxon.com/ |
| dbp:keyPeople |
* Aram Mangasarian, CEO * Maurizio PetitBon, Chairman of the supervisory board * Jens P. Furste, Founder (en) |
| dbp:location |
dbr:Berlin dbr:Germany |
| dbp:logo |
NOXXON logo HD2.png (en) |
| dbp:name |
Noxxon Pharma (en) |
| dbp:numEmployees |
10 (xsd:integer) |
| dbp:type |
dbr:Aktiengesellschaft |
| dbp:wikiPageUsesTemplate |
dbt:Infobox_company dbt:Third_party |
| dcterms:subject |
dbc:Biotechnology_companies_established_in_1997 dbc:Pharmaceutical_companies_established_in_1997 dbc:German_brands dbc:Biotechnology_companies_of_Germany dbc:Pharmaceutical_companies_of_Germany dbc:German_companies_established_in_1997 dbc:Medical_and_health_organisations_based_in_Berlin |
| gold:hypernym |
dbr:Company |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfGermany yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesEstablishedIn1997 yago:WikicatPharmaceuticalCompaniesOfGermany |
| rdfs:comment |
Noxxon Pharma is a biotechnology company founded in 1997 in Berlin, Germany and is focused on improving cancer treatment by targeting the tumor microenvironment. Noxxon Pharma N.V. is listed on Euronext Growth, Paris (ALNOX). The company is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa). The L-RNA are resistant to the natural RNA nuclease enzymes. (en) |
| rdfs:label |
Noxxon Pharma (en) |
| owl:sameAs |
freebase:Noxxon Pharma yago-res:Noxxon Pharma wikidata:Noxxon Pharma https://global.dbpedia.org/id/PxkM |
| skos:closeMatch |
http://www.grid.ac/institutes/grid.429831.5 |
| prov:wasDerivedFrom |
wikipedia-en:Noxxon_Pharma?oldid=1110582287&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/NOXXON_logo_HD2.png |
| foaf:homepage |
http://www.noxxon.com/ |
| foaf:isPrimaryTopicOf |
wikipedia-en:Noxxon_Pharma |
| foaf:name |
Noxxon Pharma (en) |
| is dbo:wikiPageRedirects of |
dbr:Noxxon dbr:NOXXON_Pharma dbr:NOX-A12 |
| is dbo:wikiPageWikiLink of |
dbr:List_of_pharmaceutical_companies dbr:Noxxon dbr:NOXXON_Pharma dbr:Mirror_life dbr:Ambigram dbr:NOX-A12 |
| is foaf:primaryTopic of |
wikipedia-en:Noxxon_Pharma |
